1-5 of 5
Jianying Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P3-06-25: Humanized patient-derived xenograft models of triple-negative breast cancer for analyzing the safety and effectiveness of mRNA lipid nanoparticle cancer vaccines

Free
Maria F. Chervo, Wei Qian, Karina A. Ortega-Martinez, Jianying Zhou, Raghav Shroff, Chiara Mancino, Liliana Guzman-Rojas, Francesca Taraballi, John P. Cooke, Jimmy D. Gollihar, Jenny C. Chang
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (12_Supplement): P3-06-25.
https://doi.org/10.1158/1557-3265.SABCS24-P3-06-25
Published: 13 June 2025
View articletitled, Abstract P3-06-25: Humanized patient-derived xenograft models of triple-negative breast cancer for analyzing the safety and effectiveness of mRNA lipid nanoparticle cancer vaccines
Journal Articles

Abstract P2-06-06: The Role of iNOS Inhibition in Enhancing Chemotherapy Efficacy by Modulating the Tumor Microenvironment in Obese TNBC Models

Free
Ivonne Uzair, Jenying Deng, Sean Hynes, Karina Ortega-Martinez, Kai Sun, Wei Qian, Jianying Zhou, Polina Matre, Jenny C Chang
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (12_Supplement): P2-06-06.
https://doi.org/10.1158/1557-3265.SABCS24-P2-06-06
Published: 13 June 2025
View articletitled, Abstract P2-06-06: The Role of iNOS Inhibition in Enhancing Chemotherapy Efficacy by Modulating the Tumor Microenvironment in Obese TNBC Models
Journal Articles

HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non–Small Cell Lung Cancer

Available to Purchase
Tao Jiang, Qiqi Jin, Jiahao Wang, Fengying Wu, Jian Chen, Gongyan Chen, Yunchao Huang, Jianhua Chen, Ying Cheng, QiMing Wang, Yueyin Pan, Jianying Zhou, Jianhua Shi, Xingxiang Xu, LiZhu Lin, Wei Zhang, Yiping Zhang, Yunpeng Liu, Yong Fang, Jifeng Feng, Zhehai Wang, Sheng Hu, Jian Fang, Yongqian Shu, Jiuwei Cui, Yi Hu, Wenxiu Yao, Xingya Li, Xiaoyan Lin, Rui Wang, Yongsheng Wang, Wei Shi, Gaohua Feng, Jun Ni, Beibei Mao, Dandan Ren, Huaibo Sun, Henghui Zhang, Luonan Chen, Caicun Zhou, Shengxiang Ren
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (23): 4830–4843.
https://doi.org/10.1158/1078-0432.CCR-23-0604
Published: 01 December 2023
View articletitled, HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non–Small Cell Lung Cancer
Open the PDF for HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis

Open Access
Chong Kin Liam, Azura Rozila Ahmad, Te-Chun Hsia, Jianying Zhou, Dong-Wan Kim, Ross Andrew Soo, Ying Cheng, Shun Lu, Sang Won Shin, James Chih-Hsin Yang, Yiping Zhang, Jun Zhao, Karin Berghoff, Rolf Bruns, Andreas Johne, Yi-Long Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (10): 1879–1886.
https://doi.org/10.1158/1078-0432.CCR-22-3318
Published: 15 May 2023
View articletitled, Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis
Open the PDF for Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis in another window
Includes: Supplementary data
Journal Articles

A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non–Small Cell Lung Cancer: a Multicenter Phase I/II Study

Open Access
Qing Zhou, Lin Wu, Pei Hu, Tongtong An, Jianying Zhou, Li Zhang, Xiao-Qing Liu, Feng Luo, Xin Zheng, Ying Cheng, Nong Yang, Junling Li, Jifeng Feng, Baohui Han, Yong Song, Kai Wang, Li Zhang, Jian Fang, Hong Zhao, Yongqian Shu, Xiao-Yan Lin, Zhihong Chen, Bin Gan, Wan-Hong Xu, Wei Tang, Xiaoying Zhang, Jin-Ji Yang, Xiao Xu, Yi-Long Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (6): 1127–1135.
https://doi.org/10.1158/1078-0432.CCR-21-2595
Published: 15 March 2022
View articletitled, A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non–Small Cell Lung Cancer: a Multicenter Phase I/II Study
Open the PDF for A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non–Small Cell Lung Cancer: a Multicenter Phase I/II Study in another window
Includes: Supplementary data